✦ LIBER ✦

Non-pegylated liposomal doxorubicin combined with gemcitabine as first-line treatment for metastatic or locally advanced breast cancer. Final results of a phase I/II trial

✍ Scribed by S. Del Barco; R. Colomer; L. Calvo; I. Tusquets; E. Adrover; P. Sánchez; J. Rifà; J. De la Haba; J. A. Virizuela

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase I/II study of vinorelbine, doxor

✍ Smitha Subramanyan; Martin D. Abeloff; Stephen E. Bond; Nancy E. Davidson; John 📂 Article 📅 1999 🏛 Springer 🌐 English ⚖ 86 KB

Final results of a phase II study ofnab-

✍ Christopher Lobo; Gilberto Lopes; Odalys Baez; Aurelio Castrellon; Annapoorna Fe 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 268 KB

Docetaxel/gemcitabine or cisplatin/gemci

✍ D. Binder; H. Schweisfurth; C. Grah; C. Schäper; B. Temmesfeld-Wollbrück; G. Sie 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 340 KB

A phase I/randomized phase II, non-compa

✍ Roger B. Cohen; Corey J. Langer; George Rajan Simon; Peter David Eisenberg; John 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 387 KB